Physician profile
Robert M Amory
NPI 1013910116
$1,348.38
in general payments reported to CMS, 2019-2025
17 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $377 · 2020: $21.72 · 2022: $164 · 2023: $333 · 2024: $452.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $785.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $785.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $269.78 | 2022-2024 | Camzyos, Eliquis |
| Silk Road Medical, INC. | $200.00 | 2024 | Enroute Transcarotid Neuroprotection System, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter, Enroute Transcarotid Stent |
| Kestra Medical Technology Services, INC. | $195.32 | 2024 | Assure Wcd |
| Abbott Laboratories | $128.53 | 2023 | Mitraclip |
| Amgen INC. | $92.54 | 2019 | |
| Biosense Webster, INC. | $67.34 | 2023 | Carto 3 |
| Actelion Pharmaceuticals US, INC. | $63.03 | 2019 | |
| Janssen Pharmaceuticals, INC | $52.10 | 2019 | |
| Novartis Pharmaceuticals Corporation | $46.80 | 2019-2023 | |
| Astrazeneca Pharmaceuticals Lp | $43.19 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $35.87 | 2019 | |
| Irhythm Technologies, INC. | $34.68 | 2022 | |
| Sanofi-Aventis U.S. LLC | $31.35 | 2019 | |
| Pfizer INC. | $27.14 | 2019 | |
| Cardiva Medical, INC. | $21.72 | 2020 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Surmodics, INC. | $20.24 | 2022 | |
| Lantheus Medical Imaging, INC. | $18.75 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Amory listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.